The aim of this study was to determine if dietary supplementation with curcumin reduce plasma levels of peptides, GSK-3β and IAPP that are implicated in the insulin resistance in people at a high risk of developing T2D. The gene discussed is GSK3B; the disease is Insulin resistance.